An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.
Gene Duo Protects Blood Vessel Health
October 6, 2022
Two genes working in concert sustain the integrity of healthy blood vessels, Weill Cornell Medicine investigators discovered in new research. The findings could lead to new approaches treating cardiovascular disease or other inflammatory conditions.
Autumn 2022 EIPM External Newsletter
October 4, 2022
Autumn 2022
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our third quarterly external newsletter of 2022!
Cross-campus initiative to accelerate innovations in engineering, medicine
September 29, 2022
Weill Cornell Medicine and Cornell Engineering are launching Engineering Innovations in Medicine, an initiative that will form unconventional partnerships that transcend academic disciplines to find solutions for such diseases as Alzheimer’s, cancer and diabetes.
Novel Technique Reveals Surprising New Way to Suppress Tumor Cells
September 27, 2022
By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced. The work, published Sept. 27 in Cell Reports, reveals a new aspect of tumor cell biology, and points to a promising strategy for treating many types of cancer.
Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry
September 19, 2022
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their analysis of TNBC tumors from a diverse patient population yielded a large set of genes whose expression differed in patients with African ancestry compared with patients with European ancestry.
Alzheimer’s Disease Causes Major Metabolic Changes in the Brain
September 14, 2022
A collaboration between Weill Cornell Medicine scientists and other leaders in Alzheimer’s disease research has revealed widespread metabolic changes in the brains of individuals with Alzheimer’s disease. The findings could lead to the development of new treatments aimed at ameliorating the metabolic effects of the disease.
USF Health, Weill Cornell Medicine Earn Inaugural Funding in NIH’s Newly Launched Bridge2AI Initiative, will Create Artificial Intelligence Platform for Using Voice to Diagnose Disease
September 13, 2022
Tampa FL (Sept. 13, 2022) – Artificial intelligence may soon help doctors diagnose and treat diseases, including cancer and depression, based on the sound of a patient’s voice, as 12 leading research institutions launch a landmark National Institutes of Health-funded academic project that may establish voice as a biomarker used in clinical care.
Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry
September 5, 2022
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their analysis of TNBC tumors from a diverse patient population yielded a large set of genes whose expression differed in patients with African ancestry compared with patients with European ancestry.
September 2022 EIPM Director's Memo
September 1, 2022
Dear Members of the Englander Institute,
I hope you were able to take some time off this summer and relax with friends and family members, and hopefully recharge for a productive autumn.
As you’ll see below, members of the EIPM had a very productive August, with significant news media coverage of our work, presentations at major international conferences, and impactful publications in high-profile journals. Thank you all for the great work during the heat of the summer!